AstraZeneca-Oxford’s COVID-19 vaccine safety questions answered

HEALTH-CORONAVIRUS/KOSOVO-VACCINE

The recommendation to pause AstraZeneca-Oxford COVID-19 vaccinations among Canadians under age 55 has prompted questions. It follows concerns the vaccine might be linked to a rare blood clotting condition. Here are some answers on the ongoing investigations.

View original article here Source

Related Posts